Brunswick Corporation filings document the public-company reporting of a marine recreation manufacturer with common stock and listed senior notes. Form 8-K reports include quarterly and annual earnings releases, non-GAAP financial measures used in management reporting, dividend-related and other material events, and debt-capital actions involving senior notes.
Proxy materials cover governance, shareholder voting matters, capital-structure disclosure, and operating and financial results. Other filings in the record document note tender offers, redemptions, and exchange notifications, including the removal from listing and registration of a senior note class.
Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 657 shares of common stock at $66.11 (code A). Following this, the director beneficially owns 9,913 shares, held directly.
Footnotes state the acquired shares are deferred shares deposited into the director’s deferred account, to be distributed in predetermined installments after the director ceases serving on the board. Beneficial holdings include 61 shares acquired via dividend reinvestment in September 2025.
Brunswick Corporation (BC) director Reginald Fils-Aime reported acquiring 681 shares of common stock at $66.11 on 10/31/2025.
After this transaction, his directly held position totaled 10,324 shares. No derivative securities were reported.
Brunswick Corporation (BC) reported an insider transaction by director Lauren Patricia Flaherty. On 10/31/2025, 633 shares of common stock were acquired at $66.11, recorded as deferred shares deposited in a director deferred account. Following the transaction, beneficial ownership stood at 16,343 shares. Beneficial holdings include 103 shares acquired through dividend reinvestments in September 2025.
Brunswick Corporation (BC) reported insider activity by a director on Form 4. The filing shows a purchase of 667 shares of common stock on 10/31/2025 at $63.11 per share, followed by a sale of 233 shares on 11/03/2025 at $64.12 per share.
Following these transactions, the director beneficially owned 27,316 shares after the purchase and 27,083 shares after the sale, held in direct ownership.
Brunswick Corporation (BC) director reported an insider acquisition. On 10/31/2025, the director acquired 846 shares of common stock at $66.11, recorded as deferred shares credited to the director’s deferred account. Following the transaction, beneficial ownership stands at 37,108 shares, held directly.
The deferred shares will be automatically distributed in predetermined installments after the individual ceases serving as a director. Beneficial holdings include 238 shares acquired through dividend reinvestments in September 2025.
Brunswick Corp (BC) reported an insider transaction on Form 4. Director Joseph W. McClanathan acquired 1,132 shares of common stock on 10/31/2025 at $66.11 per share (Transaction Code A). Following the transaction, he beneficially owns 25,842 shares. The filing notes that 499 of these shares are deferred and will be distributed in installments after he ceases being a director, and that holdings include 135 shares acquired via dividend reinvestment in September 2025.
Brunswick Corporation (BC) reported an insider transaction by a director. On 10/31/2025, the director acquired 1,189 shares of common stock at $66.11 per share. Following the transaction, the director beneficially owns 34,072 shares directly and 19,789 shares indirectly via the Barbara B Singer 2014 Irrevocable Trust.
The filing notes that 499 shares are deferred shares in the director’s deferred account to be distributed in predetermined installments after board service ends, and holdings include 166 shares acquired through dividend reinvestment in September 2025.
Brunswick Corporation (BC) director reported acquiring 662 shares of common stock at $66.11 on October 31, 2025.
Following the transaction, the director beneficially owned 65,773 shares. The filing notes these include deferred shares that will be distributed after board service ends and 426 shares acquired through dividend reinvestments in September 2025.
Brunswick Corporation (BC) filed a Form 144 notice for a proposed sale of common stock. The filing lists 233 shares to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $15,403.63 and an approximate sale date of 11/03/2025. The shares were acquired on 10/31/2025 as stock awards to board members. Shares outstanding were 65,036,590, providing scale for the transaction.
Brunswick Corporation (BC) announced debt redemptions. The company will fully redeem its 6.500% Senior Notes due 2048 and partially redeem its 6.375% Senior Notes due 2049 on December 1, 2025. The 2048 Notes redemption covers $185.0 million principal at $25.207639 per $25 principal, equal to 100% of principal plus accrued interest to, but not including, the redemption date. The 2049 Notes partial redemption covers $15.0 million principal at $25.203646 per $25, also equal to 100% of principal plus accrued interest.
After these actions, no 2048 Notes will remain outstanding and $215 million aggregate principal of 2049 Notes will remain outstanding. The aggregate redemption price for all Notes being redeemed is $201.7 million.